Correction: Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology

Affiliations

• ¹ Department of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.
• ² Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.
• ³ Medical Genome Facility, Proteomics Core, Mayo Clinic, Rochester, MN, USA.
• ⁴ Department of Neuroscience, Mayo Clinic, Scottsdale, AZ, 85259, USA.
• ⁵ Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
• ⁶ Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, 576104, India.
• ⁷ Department of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA. zhao.na@mayo.edu.
• ⁸ SciNeuro Pharmaceuticals, Rockville, MD, 20805, USA. zhao.na@mayo.edu.
• ⁹ Department of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA. guojun.bu@molecularneurodegeneration.org.
• ¹⁰ SciNeuro Pharmaceuticals, Rockville, MD, 20805, USA. guojun.bu@molecularneurodegeneration.org.